Rezolute (RZLT) Net Equity Issued and Repurchased (2010 - 2022)
Rezolute (RZLT) reported Net Equity Issued and Repurchased of $12.3 million for Q3 2022, up 927.5% on a YoY basis from $1.2 million in Q3 2021, and up 1232900.0% sequentially from $1000.0 in Q2 2022.
Rezolute (RZLT) Net Equity Issued and Repurchased (2010 - 2022) Analysis & Trends
Rezolute (RZLT) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $12.3 million in Q3 2022.
- For the quarter ending Q3 2022, Net Equity Issued and Repurchased rose 927.5% year-over-year to $12.3 million; the trailing twelve-month figure through Jun 2023 stood at $12.3 million (up 952.05% YoY), and the FY2025 full-year result was $76.2 million, up 55.44% from the prior year.
- Net Equity Issued and Repurchased rose to $12.3 million in Q3 2022, from $1000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $49.5 million in Q4 2021 to a low of -$49.6 million in Q1 2022.
- A 4-year average of $4.3 million and a median of $1.5 million in 2020 frame the typical range for Net Equity Issued and Repurchased.
- Across the five-year window, Net Equity Issued and Repurchased jumped 139.47% in 2020 and surged 3202.53% in 2021, its largest moves.
- Tracing RZLT's Net Equity Issued and Repurchased over 4 years: stood at -$3.8 million in 2019, then surged by 139.47% to $1.5 million in 2020, then surged by 3202.53% to $49.5 million in 2021, then sank by 75.11% to $12.3 million in 2022.
- Business Quant data shows RZLT's Net Equity Issued and Repurchased at $12.3 million in Q3 2022, $1000.0 in Q2 2022, and -$49.6 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 12.33 Mn |
| Sep 30, 2022 | 12.33 Mn |
| Jun 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -49.57 Mn |
| Mar 31, 2022 | -49.57 Mn |
| Dec 31, 2021 | 49.54 Mn |
| Dec 31, 2021 | 49.54 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Dec 31, 2020 | 1.50 Mn |
| Dec 31, 2020 | 1.50 Mn |
| Jun 30, 2020 | 24.05 Mn |
| Jun 30, 2020 | 24.05 Mn |
| Dec 31, 2019 | -3.80 Mn |
| Dec 31, 2019 | -3.80 Mn |
| Sep 30, 2019 | 3.80 Mn |
| Sep 30, 2019 | 3.80 Mn |
| Sep 30, 2017 | 4.50 Mn |
| Sep 30, 2017 | 4.50 Mn |